MedDeviceGuide — IVD & Medical Device Knowledge Base
Washer-Disinfector Validation for Medical Devices: ISO 15883, Thermal Disinfection, Process Parameters, and Routine Monitoring
Equipment and process validation guide for washer-disinfectors in medical device reprocessing — covering ISO 15883 series parts 1–7, IQ/OQ/PQ methodology, A₀ value concept, load configurations, chemical dosing, temperature monitoring, microbiological endpoints, maintenance, and deviation handling.
EU MDR Well-Established Technologies (WET): Expanded Device List 2026 — Delegated Acts C(2026) 1798 & 1809
On March 20, 2026, the European Commission adopted two delegated regulations expanding the Well-Established Technology (WET) list under EU MDR. C(2026) 1798 exempts additional implantable and Class III devices from clinical investigations. C(2026) 1809 simplifies conformity assessment for Class IIb implantable devices. This guide covers what changed, which devices qualify, WET criteria, and practical steps for manufacturers.
Health Canada Medical Device Regulation Reform 2026: Terms & Conditions, AI/ML Guidance, REP, and Lifecycle Oversight
Health Canada's 2026 regulatory reforms introduce expanded Terms & Conditions (T&C) powers for Class II–IV devices, new AI/ML-enabled medical device guidance, mandatory Regulatory Enrolment Process (REP), IMDRF Table of Contents requirements, and updated significant change guidance. This guide covers every major change effective January–April 2026 and what foreign manufacturers must do to maintain Canadian market access.
Medical Device Cybersecurity Penetration Testing & Vulnerability Assessment: FDA & EU MDR Requirements for 2026
FDA's February 2026 cybersecurity guidance and Section 524B of the FD&C Act make penetration testing, vulnerability scanning, and fuzz testing mandatory evidence for connected medical device submissions. This guide covers what testing is required, how to structure results, common FDA deficiencies, EU MDR cybersecurity expectations, and how to build a testing program that satisfies both regulatory frameworks.
CMS-FDA RAPID Coverage Pathway: Fast-Track Medicare Coverage for Breakthrough Devices
On April 23, 2026, CMS and FDA announced the RAPID pathway — a new initiative that could deliver Medicare national coverage within 60–90 days of FDA authorization for eligible Breakthrough Devices. This guide explains eligibility requirements, how the pathway works, IDE study design implications, and what manufacturers must do to prepare.
FDA Cybersecurity Guidance Updated for QMSR (February 2026): What Medical Device Manufacturers Must Change
On February 3, 2026, the FDA reissued its premarket cybersecurity guidance aligned with the new Quality Management System Regulation (QMSR) and ISO 13485:2016. This guide covers what changed, what stayed the same, how to map cybersecurity to ISO 13485 clauses, and practical steps for manufacturers building connected devices in 2026.
FDA General Wellness Policy for Wearable Devices (2026): What Qualifies as a Non-Regulated Wellness Product
On January 6, 2026, the FDA significantly expanded its General Wellness policy, now allowing certain wearable devices that estimate blood pressure, blood glucose, oxygen saturation, and other physiologic parameters to qualify as non-regulated wellness products. This guide covers the new criteria, FDA's illustrative examples, the line between wellness and medical device claims, and what manufacturers must do to stay compliant.
Medical Device Recall Trends 2024–2026: Statistics, Root Causes, and What Manufacturers Must Do
Data-driven analysis of medical device recall trends through 2024–2026 — 1,059 recall events, Class I recalls at a 15-year high, device failure as the new #1 cause, ~440 million units affected (up 55%), software defect trends, FDA early alert pilot, and risk mitigation strategies for manufacturers.
Medical Device Third-Party Vendor Cybersecurity Risk Management: FDA Requirements, QMSR, and Compliance Guide
Complete guide to third-party vendor cybersecurity risk management for medical devices — FDA Section 524B, QMSR ISO 13485 alignment, SBOM requirements, vendor risk assessment frameworks, MITRE threat modeling, and implementation strategies for connected device manufacturers.
RAC Certification Guide 2026: How to Prepare for the RAPS Regulatory Affairs Certification Exam
Complete guide to the RAPS Regulatory Affairs Certification (RAC) in 2026 — RAC-Devices vs RAC-Drugs, eligibility requirements, exam content, 2026 testing windows, study strategies, preparation resources, and how RAC certification advances your regulatory affairs career.
AR/VR Medical Devices: Regulatory Pathway, FDA-Cleared Devices, and Classification Guide (2026)
Complete guide to augmented reality and virtual reality medical device regulation — FDA classification, product codes, 510(k) vs De Novo pathways, the 104 FDA-cleared AR/VR devices, surgical navigation, therapeutic VR, and human factors requirements in 2026.
Medical Device Trade Shows & Conferences 2026: The Complete Global Calendar
Comprehensive guide to every major medical device trade show and conference in 2026 — including MEDICA, MD&M West, AdvaMed, RAPS Regulatory Convergence, DeviceTalks, and 50+ events worldwide with dates, locations, and what each event delivers.
Regulatory Affairs Career Guide for Medical Devices: Paths, Salaries, Certifications, and Skills in 2026
Complete career guide for medical device regulatory affairs professionals — career paths from entry level to VP, salary ranges by role and region, RAC certification details, essential skills, and how to break into the field in 2026.
ISO 17025 Test Laboratory Selection for Medical Devices: Complete Guide
How to select an ISO 17025 accredited testing laboratory for medical device biocompatibility, EMC, safety, and sterilization testing — including FDA ASCA program, scope verification, and cost considerations.
Medical Device Interoperability: HL7, FHIR, and Connected Device Standards in 2026
How HL7 FHIR, IEEE 11073, and DICOM standards enable medical device data interoperability — including the Caliper Accelerator, CMS mandates, FDA premarket expectations, and implementation guidance for manufacturers.
Privacy by Design for Medical Devices: A Practical Guide to Data Protection in Connected Healthcare
How to implement Privacy by Design principles in medical device development — covering GDPR, HIPAA, data minimization, consent management, anonymization, and the 2026 regulatory landscape for connected devices and wearables.
Agile vs Waterfall for Medical Device Software: IEC 62304, Design Controls, and Audit Evidence
How to choose between Agile and Waterfall for medical device software development under IEC 62304 — AAMI TIR45 guidance, design control mapping, hybrid models, and what auditors actually look for.
ASTM D4169 Transportation Validation for Medical Device Packaging: Distribution Simulation, Distribution Cycles, Assurance Levels, and Acceptance Criteria
Complete guide to ASTM D4169 performance testing for medical device packaging — distribution cycle selection (DC-13, DC-6, DC-12), assurance levels (I, II, III), test schedules (drop, compression, vibration, low pressure, impact), pre-conditioning per ASTM D4332, relationship to ISO 11607 sterile barrier validation, FDA 510(k) requirements, sample size justification, acceptance criteria development, common pitfalls, and step-by-step implementation guide.
Australia Medical Device Registration Cost 2026: Australian Sponsor Pricing Models, Flat Fee vs Hourly Billing, and 3-Year Cash Flow Comparison
How much does it cost to register a medical device in Australia in 2026? A buyer-side breakdown of Australian Sponsor service pricing — hourly billing, registration-fee-plus-annual, and flat all-inclusive fee — with worked 3-year cash flow scenarios for ARTG inclusion across Class I through Class III/AIMD devices.
Bangladesh DGDA Medical Device Registration Guide: Classification, Import Permits, and Local Representative Requirements
Complete guide to registering medical devices in Bangladesh through the Directorate General of Drug Administration (DGDA) — four-tier risk classification (A–D) aligned with ASEAN MDD, two-step Recipe Approval and Final Registration process, reference country Free Sale Certificate requirements, local authorized representative obligations, import licensing and indent approval workflow, Maximum Retail Price (MRP), Bengali labeling, ISO 13485 QMS expectations, Drug and Cosmetics Act 2023, fees, timelines, and South Asia market strategy.